Page 6 - Kyoto University Graduate School News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genetic basis of speciation and adaptation: from loci to causative mutations | Philosophical Transactions of the Royal Society B: Biological Sciences

Genetic basis of speciation and adaptation: from loci to causative mutations | Philosophical Transactions of the Royal Society B: Biological Sciences
royalsocietypublishing.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from royalsocietypublishing.org Daily Mail and Mail on Sunday newspapers.

France generalUnited kingdomInstitut jacques monodMarie curieRoger butlinPatrik nosilMark ravinetAsano ishikawaTsuchimatsu fujiiJun kitanoRyo yamasakiSatoshi ansaiKazunori yamahiraQueen university belfastRoyal societyNational institute of genetics

INTERVIEW | iPS Cell Research with Shinya Yamanaka and Jun Takahashi

iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.

United statesShinya yamanakaToshiichiro itoSankei shimbunJun takahashiPs cell research foundationPs cell researchJapan society for regenerative medicineSchool of osaka city universityKyoto university ciKyoto universityPs cell research instituteKyoto university school of medicineKobe university school of medicineSalk institute for biologicalKyoto university graduate school

Bridging Japan-UK online symposium 2022

Responding to the continued waves of the COVID-19 pandemic: Reviewing the pandemic responses in Japan, UK and the rest of the world COVID-19 is still evolving with the emergence of the new Omicron variant. This ongoing pandemic continues to impact on societies, highlighting the global differences in COVID-19 responses and challenges in vaccine rollout.

United kingdomJohn edmundsKim mulhollandShunmay yeungGlobal healthHitoshi oshitaniTohoku university graduate schoolYuichi imanakaKyoto university graduate schoolRia sayoPhilippines departmentKoya ariyoshiNagasaki university schoolTropical medicineKiyoshi kitaKinuko saito

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Yutaka iijimaHayami masanoriRobertg hisaokaSachiko kunoWataru akahataRyuji uenoVaccine research centerGlobal communicationsNational institutes of healthSk impact fundCapital co ltdSojitz corporationTokyo institute of technologyBank ltdTherapeutics japanKyoto university graduate school of medicine

VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

/PRNewswire/ US-based biotech company VLP Therapeutics, Inc. (VLPT) announced on December 27 that it has signed an agreement for an investment of US$21.

Yutaka iijimaHayami masanoriSachiko kunoWataru akahataRyuji uenoVaccine research centerGlobal communicationsNational institutes of healthTokyo institute of technologyKyoto university graduate school of medicineTherapeutics japanTherapeutics incKyoto university institute for virus researchUniversity of tokyoKyoto university graduate school of humanKyoto university